Altimmune, Inc.ALTNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -38.52% |
| Q3 2025 | 9.00% |
| Q2 2025 | -5.07% |
| Q1 2025 | 12.27% |
| Q4 2024 | -0.40% |
| Q3 2024 | 7.40% |
| Q2 2024 | 0.18% |
| Q1 2024 | 20.31% |
| Q4 2023 | -49.17% |
| Q3 2023 | -25.17% |
| Q2 2023 | 17.24% |
| Q1 2023 | 5.78% |
| Q4 2022 | 6.70% |
| Q3 2022 | -21.36% |
| Q2 2022 | -4.60% |
| Q1 2022 | 18.70% |
| Q4 2021 | 27.76% |
| Q3 2021 | -33.54% |
| Q2 2021 | -67.31% |
| Q1 2021 | -38.24% |
| Q4 2020 | 41.34% |
| Q3 2020 | 0.51% |
| Q2 2020 | -152.07% |
| Q1 2020 | -69.45% |
| Q4 2019 | 61.75% |
| Q3 2019 | -217.48% |
| Q2 2019 | -52.49% |
| Q1 2019 | 91.48% |
| Q4 2018 | -573.87% |
| Q3 2018 | 25.35% |
| Q2 2018 | 9.32% |
| Q1 2018 | 52.29% |
| Q4 2017 | 59.41% |
| Q3 2017 | -671.64% |
| Q2 2017 | -26.01% |
| Q1 2017 | 42.25% |
| Q4 2016 | -38.16% |
| Q3 2016 | -685.79% |
| Q2 2016 | 59.52% |
| Q1 2016 | -33.38% |